# Pivotal Study of the Velocity™ pAVF System

> **NCT07153939** · NA · RECRUITING · sponsor: **Venova Medical** · enrollment: 126 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Hemodialysis Access
- Arteriovenous Fistula
- End Stage Renal Disease (ESRD)

## Interventions

- **DEVICE:** Velocity Percutaneous Arteriovenous Fistula

## Key facts

- **NCT ID:** NCT07153939
- **Lead sponsor:** Venova Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2026-09
- **Final completion:** 2030-09
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07153939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07153939, "Pivotal Study of the Velocity™ pAVF System". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT07153939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*